Sign in or create an account to add this stock to your watchlist.
About Tivity Health (NASDAQ:TVTY)
Tivity Health, Inc. provides fitness and health improvement programs in the United States. The company offers SilverSneakers senior fitness program to the members of Medicare advantage, Medicare supplement, and group retiree plans; and Prime fitness, a fitness facility access program through commercial health plans and employers. It also provides health plans through WholeHealth Living program; and health services, such as chiropractic care, acupuncture, physical therapy, occupational therapy, speech therapy, and others. The company was formerly known as Healthways, Inc. and changed its name to Tivity Health, Inc. in January 2017. Tivity Health, Inc. was founded in 1981 and is headquartered in Franklin, Tennessee.
Industry, Sector and Symbol
Industry Miscellaneous health & allied services, not elsewhere classified
Sub-IndustryHealth Care Services
SectorMedical
SymbolNASDAQ:TVTY
CUSIP42224510
Phone615-614-4929
Debt
Debt-to-Equity RatioN/A
Current Ratio0.70
Quick Ratio0.70
Price-To-Earnings
Trailing P/E Ratio21.75
Forward P/E Ratio17.82
P/E Growth1.62
Sales & Book Value
Annual Sales$556.94 million
Price / Sales2.76
Cash Flow$2.1629 per share
Price / Cash17.80
Book Value$7.39 per share
Price / Book5.21
Profitability
EPS (Most Recent Fiscal Year)$1.68
Net Income$63.71 million
Net Margins12.33%
Return on Equity28.62%
Return on Assets11.51%
Miscellaneous
Employees475
Outstanding Shares39,880,000
Tivity Health (NASDAQ:TVTY) Frequently Asked Questions
What is Tivity Health's stock symbol?
Tivity Health trades on the NASDAQ under the ticker symbol "TVTY."
How were Tivity Health's earnings last quarter?
Tivity Health Inc (NASDAQ:TVTY) posted its quarterly earnings data on Monday, April, 23rd. The company reported $0.49 EPS for the quarter, meeting the Zacks' consensus estimate of $0.49. The company had revenue of $149.90 million for the quarter, compared to analyst estimates of $154.32 million. Tivity Health had a net margin of 12.33% and a return on equity of 28.62%. The company's quarterly revenue was up 6.3% on a year-over-year basis. During the same period in the prior year, the firm posted $0.42 EPS. View Tivity Health's Earnings History.
When is Tivity Health's next earnings date?
What guidance has Tivity Health issued on next quarter's earnings?
Tivity Health issued an update on its FY18 earnings guidance on Monday, April, 23rd. The company provided EPS guidance of $2.12-2.20 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $2.16. The company issued revenue guidance of $607-625 million, compared to the consensus revenue estimate of $617.52 million.
What price target have analysts set for TVTY?
8 analysts have issued twelve-month price targets for Tivity Health's shares. Their forecasts range from $41.00 to $53.00. On average, they anticipate Tivity Health's stock price to reach $47.3750 in the next year. View Analyst Ratings for Tivity Health.
What are Wall Street analysts saying about Tivity Health stock?
Here are some recent quotes from research analysts about Tivity Health stock:
- 1. According to Zacks Investment Research, "Tivity Health, Inc. provides health management services. The company offers services which include chiropractic services, physical therapy, occupational therapy, speech therapy, acupuncture, massage and complementary and alternative medicine services. Its network comprises SilverSneakers(R), Prime(R) Fitness and WholeHealth Living (TM). Tivity Health, Inc., formerly known as Healthways, Inc., is based in Franklin, Tennessee. " (4/26/2018)
- 2. Cantor Fitzgerald analysts commented, "Mixed 1Q18 results. Revenue of $150 million (+6.4% y/y) was below our estimate of $156 million and consensus of $154 million. Adjusted EBITDA margins remained healthy at 22.1%. Adjusted EPS of $0.49 were in line with consensus but below our estimate of $0.52." (4/23/2018)
Who are some of Tivity Health's key competitors?
Who are Tivity Health's key executives?
Tivity Health's management team includes the folowing people:
- Mr. Donato J. Tramuto, CEO & Director (Age 61)
- Mr. Glenn Hargreaves, Chief Accounting Officer & Controller (Age 51)
- Ms. Mary S. Flipse, Chief Legal Officer (Age 51)
- Mr. Adam C. Holland, Chief Financial Officer (Age 39)
- Mr. Paul Edmisten, Chief Information Officer
Has Tivity Health been receiving favorable news coverage?
News stories about TVTY stock have trended somewhat positive recently, Accern reports. Accern identifies positive and negative press coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Tivity Health earned a coverage optimism score of 0.18 on Accern's scale. They also assigned press coverage about the company an impact score of 45.33 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company's share price in the near future.
Who are Tivity Health's major shareholders?
Tivity Health's stock is owned by many different of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (11.70%), Neuberger Berman Group LLC (5.84%), Dimensional Fund Advisors LP (3.93%), Eagle Asset Management Inc. (3.82%), American Century Companies Inc. (3.19%) and Hood River Capital Management LLC (3.10%). Company insiders that own Tivity Health stock include Conan Laughlin, Donato Tramuto, Glenn Hargreaves, Mary Flipse, Mary Jane England and Robert J Greczyn Jr. View Institutional Ownership Trends for Tivity Health.
Which major investors are selling Tivity Health stock?
TVTY stock was sold by a variety of institutional investors in the last quarter, including Millennium Management LLC, Wells Fargo & Company MN, Dimensional Fund Advisors LP, Russell Investments Group Ltd., Mckinley Capital Management LLC Delaware, JPMorgan Chase & Co., Comerica Bank and Algert Global LLC. Company insiders that have sold Tivity Health company stock in the last year include Conan Laughlin, Donato Tramuto, Glenn Hargreaves and Mary Flipse. View Insider Buying and Selling for Tivity Health.
Which major investors are buying Tivity Health stock?
TVTY stock was acquired by a variety of institutional investors in the last quarter, including Monarch Partners Asset Management LLC, Van Berkom & Associates Inc., Eagle Asset Management Inc., Point72 Asset Management L.P., Nuveen Asset Management LLC, Freestone Capital Holdings LLC, Franklin Resources Inc. and Fort Washington Investment Advisors Inc. OH. Company insiders that have bought Tivity Health stock in the last two years include Donato Tramuto and Robert J Greczyn Jr. View Insider Buying and Selling for Tivity Health.
How do I buy shares of Tivity Health?
Shares of TVTY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Tivity Health's stock price today?
One share of TVTY stock can currently be purchased for approximately $38.50.
How big of a company is Tivity Health?
Tivity Health has a market capitalization of $1.54 billion and generates $556.94 million in revenue each year. The company earns $63.71 million in net income (profit) each year or $1.68 on an earnings per share basis. Tivity Health employs 475 workers across the globe.
How can I contact Tivity Health?
Tivity Health's mailing address is 701 Cool Springs Boulevard, Franklin TN, 37067. The company can be reached via phone at 615-614-4929 or via email at [email protected]
MarketBeat Community Rating for Tivity Health (TVTY)
MarketBeat's community ratings are surveys of what our community members think about Tivity Health and other stocks. Vote "Outperform" if you believe TVTY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe TVTY will underperform the S&P 500 over the long term. You may vote once every thirty days.
Tivity Health (NASDAQ:TVTY) Price Target and Consensus Rating
(How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
8 Wall Street analysts have issued ratings and price targets for Tivity Health in the last 12 months. Their average twelve-month price target is $47.3750, suggesting that the stock has a possible upside of 23.05%. The high price target for TVTY is $53.00 and the low price target for TVTY is $41.00. There are currently 1 hold rating and 7 buy ratings for the stock, resulting in a consensus rating of "Buy."
| Today | 30 Days Ago | 90 Days Ago | 180 Days Ago |
| Consensus Rating: | Buy | Buy | Buy | Buy |
| Consensus Rating Score: | 2.88 | 2.88 | 2.86 | 2.86 |
| Ratings Breakdown: | 0 Sell Rating(s)
1 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
1 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
1 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
1 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s) |
| Consensus Price Target: | $47.3750 | $47.3750 | $47.1429 | $45.4286 |
| Price Target Upside: | 23.05% upside | 20.09% upside | 23.90% upside | 43.76% upside |
Tivity Health (NASDAQ:TVTY) Consensus Price Target History
Tivity Health (NASDAQ:TVTY) Analyst Ratings History
Show:
(Data available from 5/27/2016 forward)
Tivity Health (NASDAQ:TVTY) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
(Data available from 1/1/2013 forward)
Tivity Health (NASDAQ TVTY) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 8.42%
Tivity Health (NASDAQ TVTY) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 5/1/2018 | Donato Tramuto | CEO | Sell | 20,000 | $35.37 | $707,400.00 | 149,596 |  |
| 4/2/2018 | Donato Tramuto | CEO | Sell | 20,000 | $39.30 | $786,000.00 | | |
| 3/1/2018 | Donato Tramuto | CEO | Sell | 20,000 | $38.53 | $770,600.00 | 189,596 | |
| 11/21/2017 | Conan Laughlin | Director | Sell | 140,000 | $34.90 | $4,886,000.00 | | |
| 11/17/2017 | Conan Laughlin | Director | Sell | 490,000 | $34.34 | $16,826,600.00 | | |
| 11/15/2017 | Conan Laughlin | Director | Sell | 115,087 | $33.87 | $3,897,996.69 | | |
| 11/6/2017 | Conan Laughlin | Director | Sell | 120,000 | $47.52 | $5,702,400.00 | | |
| 11/3/2017 | Mary Flipse | Insider | Sell | 5,000 | $48.11 | $240,550.00 | 45,167 | |
| 11/2/2017 | Glenn Hargreaves | CAO | Sell | 5,805 | $45.15 | $262,095.75 | 44,448 | |
| 9/26/2017 | Glenn Hargreaves | Insider | Sell | 7,137 | $40.00 | $285,480.00 | 52,180 | |
| 9/25/2017 | Mary Flipse | Insider | Sell | 7,808 | $39.00 | $304,512.00 | 57,975 | |
| 8/21/2017 | Glenn Hargreaves | Insider | Sell | 23,448 | $37.78 | $885,865.44 | 62,211 | |
| 8/18/2017 | Mary Flipse | Insider | Sell | 14,020 | $37.03 | $519,160.60 | 61,167 | |
| 8/11/2017 | Mary Flipse | Insider | Sell | 1,340 | $37.32 | $50,008.80 | 75,187 | |
| 8/4/2017 | Glenn Hargreaves | Insider | Sell | 21,105 | $38.00 | $801,990.00 | 59,077 | |
| 8/1/2017 | Conan Laughlin | Director | Sell | 1,750,000 | $37.90 | $66,325,000.00 | | |
| 5/3/2017 | Mary Jane England | Director | Sell | 1,763 | $31.95 | $56,327.85 | 19,453 | |
| 4/3/2017 | Mary Jane England | Director | Sell | 2,674 | $29.05 | $77,679.70 | 21,216 | |
| 3/3/2017 | Mary Jane England | Director | Sell | 2,340 | $28.60 | $66,924.00 | 23,890 | |
| 3/1/2017 | Conan Laughlin | Insider | Sell | 2,000,000 | $28.30 | $56,600,000.00 | | |
| 2/3/2017 | Mary Jane England | Director | Sell | 2,343 | $25.55 | $59,863.65 | 26,230 | |
| 1/3/2017 | Mary Jane England | Director | Sell | 2,298 | $22.40 | $51,475.20 | 28,573 | |
| 11/18/2016 | Mary Jane England | Director | Sell | 3,600 | $22.26 | $80,136.00 | 30,871 | |
| 11/4/2016 | Donato Tramuto | CEO | Buy | 5,060 | $19.95 | $100,947.00 | 275,442 | |
| 11/4/2016 | Robert J Greczyn Jr | Director | Buy | 5,000 | $19.55 | $97,750.00 | 30,578 | |
| 8/26/2016 | Mary Jane England | Director | Sell | 3,816 | $24.78 | $94,560.48 | 39,068 | |
| 11/13/2015 | Conan Laughlin | Director | Buy | 47,600 | $12.65 | $602,140.00 | 6,203 | |
| 11/12/2015 | Conan Laughlin | Director | Buy | 252,400 | $12.49 | $3,152,476.00 | 6,203 | |
| 11/5/2015 | Conan Laughlin | Director | Buy | 350,000 | $11.51 | $4,028,500.00 | 6,203 | |
| 11/3/2015 | Donato Tramuto | CEO | Buy | 8,740 | $11.47 | $100,247.80 | 304,186 | |
| 11/3/2015 | Lee Shapiro | Director | Buy | 4,359 | $11.42 | $49,779.78 | 10,562 | |
| 7/31/2014 | North Tide Capital, Llc | Major Shareholder | Sell | 100,000 | $17.29 | $1,729,000.00 | | |
| 12/18/2013 | North Tide Capital, Llc | major shareholder | Buy | 140,000 | $14.11 | $1,975,400.00 | | |
| 11/7/2013 | Donato Tramuto | Director | Buy | 4,200 | $11.77 | $49,434.00 | 4,200 | |
| 10/29/2013 | Alfred Lumsdaine | CFO | Buy | 5,000 | $10.80 | $54,000.00 | | |
| 8/14/2013 | Alfred Lumsdaine | CFO | Sell | 9,425 | $18.64 | $175,682.00 | 17,821 | |
| 8/14/2013 | Ben Leedle, Jr. | CEO | Sell | 293,984 | $18.68 | $5,491,621.12 | 201,814 | |
| 6/3/2013 | Jay C Bisgard | Director | Sell | 4,869 | $14.58 | $70,990.02 | | |
| 5/17/2013 | Jay C Bisgard | Director | Sell | 2,039 | $14.50 | $29,565.50 | | |
| 5/14/2013 | Jay C Bisgard | Director | Sell | 18,343 | $14.51 | $266,156.93 | | |
| 5/9/2013 | John W Ballantine | Director | Sell | 27,400 | $14.02 | $384,148.00 | | |
(Data available from 1/1/2013 forward)
Tivity Health (NASDAQ TVTY) News Headlines
| Source: |
|
Tivity Health (NASDAQ:TVTY) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Tivity Health (NASDAQ:TVTY) Income Statement, Balance Sheet and Cash Flow Statement
Tivity Health (NASDAQ TVTY) Stock Chart for Sunday, May, 27, 2018
Loading chart…
